Buserelin (Acetate)
Buserelin (Acetate) Information

About Buserelin (Acetate)

Buserelin (Acetate) is analogue of gonadotrophin-releasing hormone that suppresses androgen production by testes. Buserelin (Acetate) is used in the treatment of carcinoma of prostate and endometriosis.

Indications

Buserelin (Acetate) is primarily indicated in conditions like Endometriosis, Fibroids, In-vitro fertilization programmes, Mobilisation of peripheral blood progenitor cells, Pituitary desensitisation, Polycystic ovary syndrome, Precocious puberty, Prostatic cancer, and can also be given in adjunctive therapy as an alternative drug of choice in Advanced prostate cancer.

Contraindication

Buserelin (Acetate)

Side Effects

The severe or irreversible adverse effects of Buserelin (Acetate), which give rise to further complications include Histological changes in testis.The symptomatic adverse reactions produced by Buserelin (Acetate) are more or less tolerable and if they become severe, they can be treated symptomatically, these include Menopausal symptoms, Loss of libido, Hot flushes.

Warnings

Buserelin should not generally use in patients with pituitary adenoma. It is also recommended that patients with weight related amenorrhoea should not receive this medication until their weight is corrected. It is not recommended for use during pregnancy.

High Risk Groups

Drug should not be given to Pregnant Mothers, and Neonates.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.